CXCR4 and cancer: Interestingly, inhibition of Wnt, Hedgehog, or CXCL12-CXCR4 signaling by pharmacological compounds resensitized cancer cells to gemcitabine-induced cytotoxicity, suggesting the importance of CXCL12-CXCR4 in PDAC drug resistance [92–94].